Publicacións nas que colabora con Tomás Ramón Vázquez Rodríguez (67)

2022

  1. Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure

    Seminars in Arthritis and Rheumatism, Vol. 52

2021

  1. Diagnostic delay of associated interstitial lung disease increases mortality in rheumatoid arthritis

    Scientific Reports, Vol. 11, Núm. 1

  2. Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know?

    Rheumatology (Oxford, England), Vol. 60, Núm. 11, pp. 5329-5336

2020

  1. Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER).

    Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 4, pp. 657-662

  2. Hormonal Dependence and Cancer in Systemic Lupus Erythematosus

    Arthritis Care and Research, Vol. 72, Núm. 2, pp. 216-224

2019

  1. Long-term survival of subcutaneous anti-tumor necrosis factor biological drugs administered between 2008 and 2012 in a cohort of rheumatoid arthritis patients

    Reumatologia Clinica, Vol. 15, Núm. 1, pp. 54-57

  2. Tumor-induced hypophosphatemic osteomalacia: description of 2 cases

    Medicina Clinica

2016

  1. Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: Cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry

    Rheumatology (United Kingdom), Vol. 55, Núm. 7, pp. 1243-1250

2014

  1. Investigations into audiovestibular manifestations in patients with psoriatic arthritis

    Journal of Rheumatology, Vol. 41, Núm. 10, pp. 2018-2026

2012

  1. Anti-TNF-alpha-adalimumab therapy is associated with persistent improvement of endothelial function without progression of carotid intima-media wall thickness in patients with rheumatoid arthritis refractory to conventional therapy

    Mediators of Inflammation, Vol. 2012

2011

  1. Analysis of the influence of the ghrelin receptor rs509035, rs512692 and rs2922126 polymorphisms in the risk of cardiovascular disease in patients with rheumatoid arthritis

    Clinical and Experimental Rheumatology

  2. Audiovestibular manifestations in patients with ankylosing spondylitis

    Medicine, Vol. 90, Núm. 2, pp. 99-109

  3. Benign paroxysmal positional vertigo and clinical test of sensory interaction and balance in ankylosing spondylitis

    Otology and Neurotology, Vol. 32, Núm. 2, pp. 278-283

  4. CCR5Δ32 variant and cardiovascular disease in patients with rheumatoid arthritis: A cohort study

    Arthritis Research and Therapy, Vol. 13, Núm. 4

  5. Interleukin-1 beta gene polymorphism in patients with biopsy-proven erythema nodosum

    Clinical and Experimental Rheumatology

  6. Lack of association between ADIPOQ rs266729 and ADIPOQ rs1501299 polymorphisms and cardiovascular disease in rheumatoid arthritis patients

    Tissue Antigens, Vol. 77, Núm. 1, pp. 74-78

  7. Lack of association between LEP rs2167270 (19 G>A) polymorphism and disease susceptibility and cardiovascular disease in patients with rheumatoid arthritis

    Clinical and Experimental Rheumatology, Vol. 29, Núm. 2, pp. 293-298

  8. Lack of association between RETN rs1862513 polymorphism and cardiovascular disease in patients with rheumatoid arthritis

    Clinical and Experimental Rheumatology, Vol. 29, Núm. 1, pp. 19-25

  9. Lack of association of NAMPT rs9770242 and rs59744560 polymorphisms with disease susceptibility and cardiovascular risk in patients with rheumatoid arthritis

    Clinical and Experimental Rheumatology, Vol. 29, Núm. 4, pp. 681-688

  10. Relapses and recurrences in giant cell arteritis: A population-based study of patients with biopsy-proven disease from Northwestern Spain

    Medicine, Vol. 90, Núm. 3, pp. 186-193